-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Initiates Coverage On ProQR Therapeutics with Buy Rating, Announces Price Target of $8

Benzinga·08/20/2026 12:03:54
语音播报
B of A Securities analyst Alec Stranahan initiates coverage on ProQR Therapeutics (NASDAQ:PRQR) with a Buy rating and announces Price Target of $8.